CompletedNot Applicable

Functional Outcomes and Quality of Life in Musculoskeletal Tumor Patients With Distal Femoral Megaprostheses

Spain79 participantsStarted 2018-02-01

Plain-language summary

This study aims to evaluate the functional outcomes of patients with distal femur tumor prostheses in comparison to a matched control group.

Who can participate

Age range16 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria (cases group): * Megaprosthesis of unilateral distal femur * Tumor cause * Ambulation capacity Exclusion Criteria (cases group): * Neurological alterations prior to the inervention than affect the lower limbs or general movement * Patient incapable of ambulation due to progression of his/her pathology * Patient with palliative treatment for advanced tumor diseas * More than one ipsilateral or contralateral prosthesis * Infection, traumatic or sequel to revision surgery cause

What they're measuring

SF-36 questionnaire

Timeframe: 3 months

Timed Up and Go Test

Timeframe: 3 months

6 -Minute Walk Test

Timeframe: 3 months

Trial details

NCT IDNCT06282198

SponsorCardenal Herrera University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Distal Femoral Musculoskeletal Tumors trials